Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial
Rakesh Popat, Dana Warcel, Jenny O’Nions, Anna Cowley, Sasha Smith, William Tucker, Kwee Yong, Simona Degli Esposti
Topics & Concepts
Multiple myelomaMedicineClinical trialOncologySeries (stratigraphy)Internal medicineBiologyPaleontologyMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsUbiquitin and proteasome pathways